Evidence map›Paper›PMID 35658052›Full record

SynthesisPloS one2022

The risks of RELN polymorphisms and its expression in the development of otosclerosis.

Saurabh Priyadarshi, Kirtal Hansdah, Neha Singh, Amal Bouzid, Chinmay Sundar Ray, Khirod Chandra Panda, Narayan Chandra Biswal, Ashim Desai, Jyotish Chandra Choudhury, Adel Tekari and 2 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Exploring the genetic landscape of otosclerosis: current understanding and future perspectives.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2025
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Saurabh PriyadarshiInstitute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, India.
Kirtal HansdahInstitute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, India.
Neha SinghInstitute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, India.
Amal BouzidLaboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia.
Chinmay Sundar RayDepartment of Ear, Nose, and Throat (ENT), Shrirama Chandra Bhanj (SCB) Medical College & Hospital, Cuttack, India.
Khirod Chandra PandaEar, Nose, and Throat (ENT) Unit, Capital Hospital, Unit VI, Bhubaneswar, India.
Narayan Chandra BiswalDepartment of Ear, Nose, and Throat (ENT), Shrirama Chandra Bhanj (SCB) Medical College & Hospital, Cuttack, India.
Ashim DesaiDr. ABR Desai Ear, Nose and Throat (ENT) Clinic and Research Centre, Mumbai, India.
Jyotish Chandra ChoudhuryDepartment of Forensic Medicine & Toxicology (FMT), Shrirama Chandra Bhanj (SCB) Medical College & Hospital, Cuttack, India.
Adel TekariLaboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia.ORCID 0000-0003-1676-0920
Saber MasmoudiLaboratory of Molecular and Cellular Screening Processes, Centre of Biotechnology of Sfax, University of Sfax, Sfax, Tunisia.
Puppala Venkat RamchanderInstitute of Life Sciences, Nalco Square, Chandrasekharpur, Bhubaneswar, India.ORCID 0000-0003-2225-2252
Institute of Life Sciences · INSriram Chandra Bhanja Medical College Hospital · INUniversity of Sfax · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Otosclerosis (OTSC) is the primary form of conductive hearing loss characterized by abnormal bone remodelling within the otic capsule of the human middle ear. A genetic association of the RELN SNP rs3914132 with OTSC has been identified in European population. Previously, we showed a trend towards association of this polymorphism with OTSC and identified a rare variant rs74503667 in a familial case. Here, we genotyped these variants in an Indian cohort composed of 254 OTSC cases and 262 controls. We detected a significant association of rs3914132 with OTSC (OR = 0.569, 95%CI = 0.386-0.838, p = 0.0041). To confirm this finding, we completed a meta-analysis which revealed a significant association of the rs3914132 polymorphism with OTSC (Z = 6.707, p<0.0001) across different ethnic populations. Linkage analysis found the evidence of linkage at RELN locus (LOD score 2.1059) in the OTSC family which has shown the transmission of rare variant rs74503667 in the affected individuals. To understand the role of RELN and its receptors in the development of OTSC, we went further to perform a functional analysis of RELN/reelin. Here we detected a reduced RELN (p = 0.0068) and VLDLR (p = 0.0348) mRNA levels in the otosclerotic stapes tissues. Furthermore, a reduced reelin protein expression by immunohistochemistry was confirmed in the otosclerotic tissues. Electrophoretic mobility shift assays for rs3914132 and rs74503667 variants revealed an altered binding of transcription factors in the mutated sequences which indicates the regulatory role of these variations in the RELN gene regulation. Subsequently, we showed by scanning electron microscopy a change in stapes bone morphology of otosclerotic patients. In conclusion, this study evidenced that the rare variation rs74503667 and the common polymorphism rs3914132 in the RELN gene and its reduced expressions that were associated with OTSC.

Indexed as

OtosclerosisGenetic Predisposition to DiseaseGenotypeHumansPolymorphism, Single NucleotideReelin ProteinReelin ProteinRELN protein, human

Identifiers

PMID35658052
PMCPMC9165908
OpenAlexW4281608876

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.